Gynecomastia Surgery in Hiroshima Japan

Gynecomastia Surgery
Male Breast Reduction

Based upon Wikipedia, the free encyclopedia

Gynecomastia, or gynaecomastia, is the development of abnormally large mammary glands in males resulting in breast enlargement, which can sometimes cause secretion of milk.
The term comes from the Greek gyne meaning "woman" and mastos meaning "breast".

The condition can occur physiologically in neonates (young babies), in adolescents, and in the elderly. In adolescent boys the condition is often a source of distress, but for the large majority of boys whose pubertal gynecomastia is not due to obesity, the breast development shrinks or disappears within a couple of years.

The causes of common gynecomastia remain uncertain, although it has generally been attributed to an imbalance of sex hormones or the tissue responsiveness to them; a root cause is rarely determined for individual cases.

Gynecomastia occurs in approximately 50% of all men in different forms, ranging from excess breast or fat tissue to the development of female glands.

In some cases, changes in lifestyle or diet can reverse gynecomastia, and in 90% of adolescents the condition disappears within a month or two.  For all others surgery is the only option for correction.

Causes of Gynecomastia
It can develop in adolescents as early as age twelve as a result of hormonal changes. It can also be caused by drug, diet, and lifestyle induced hormonal shifts.

Men taking anabolic steroids often suffer from gynecomastia as testosterone levels in the body rise dramatically, causing the body to respond by producing enzymes that turn excess testosterone into estrogen.
Increased age and weight can also contribute to the development of excess breast and fat tissue.

Physiologic gynecomastia occurs in neonates (young babies), at or before puberty and with aging. Many cases of gynecomastia are idiopathic, meaning they have no clear cause.
Potential pathologic causes of gynecomastia are:
• Medications including hormones;
• Increased serum estrogen;
• Decreased testosterone production;
• Androgen receptor defects;
• Chronic kidney disease;
• Chronic liver disease;
• HIV; and
• Other chronic illness.

Gynecomastia as a result of spinal cord injury and re-feeding after starvation has been reported. In 25% of cases, the cause of the gynecomastia is not known.

Medications cause 10-20% of cases of gynecomastia in post-adolescent adults. These include cimetidine, omeprazole, spironolactone, Imatinib Mesylate, finasteride and certain antipsychotics. Some act directly on the breast tissue, while others lead to increased secretion of prolactin from the pituitary by blocking the actions of dopamine (prolactin-inhibiting factor/PIF) on the lactotrope cell groups in the anterior pituitary. Androstenedione, used as a performance enhancing food supplement, can lead to breast enlargement by excess estrogen activity. Medications used in the treatment of prostate cancer, such as antiandrogens and GnRH analogs can also cause gynecomastia. Marijuana use is also thought by some to be a possible cause; however, published data is contradictory.

Increased estrogen levels can also occur in certain testicular tumors, and in hyperthyroidism. Certain adrenal tumors cause elevated levels of androstenedione which is converted by the enzyme aromatase into estrone, a form of estrogen. Other tumors that secrete hCG can increase estrogen. A decrease in estrogen clearance can occur in liver disease, and this may be the mechanism of gynecomastia in liver cirrhosis. Obesity tends to increase estrogen levels.

Decreased testosterone production can occur in congenital or acquired testicular failure, for example in genetic disorders such as Klinefelter Syndrome. Diseases of the hypothalamus or pituitary can also lead to low testosterone. Abuse of anabolic androgenic steroids (AAS) has a similar effect. Mutations to androgen receptors, such as those found in Kennedy disease can also cause gynecomastia.

Although stopping these medications can lead to regression of the gynecomastia, surgery is sometimes necessary to eliminate the condition.

Repeated topical application of products containing lavender and tea tree oils among other unidentified ingredients to three prepubescent males coincided with gynecomastia; it has been theorised that this could be due to their estrogenic and antiandrogenic activity. However, other circumstances around the study are not clear, and the sample size was insignificant so serious scientific conclusions cannot be drawn.


Diagnosis
The condition usually can be diagnosed by examination by a physician. Occasionally, imaging by X-rays or ultrasound is needed to confirm the diagnosis. Blood tests are required to see if there is any underlying disease causing the gynecomastia.


Prognosis
Gynecomastia is not physically harmful, but in some cases can be an indicator of other more dangerous underlying conditions. Growing glandular tissue, typically from some form of hormonal stimulation, is often tender or painful. Furthermore, it can frequently present social and psychological difficulties for the sufferer. Weight loss can alter the condition in cases where it is triggered by obesity, but losing weight will not reduce the glandular component and patients cannot target areas for weight loss. Massive weight loss can result in sagging tissues about the chest, chest ptosis, or drooping chest.

Treatment: non-surgical
Treating the underlying cause of the gynecomastia may lead to improvement in the condition.

Patients should talk with their doctor about revising any medications that are found to be causing gynecomastia; often, an alternative medication can be found that avoids gynecomastia side-effects, while still treating the primary condition for which the original medication was found not to be suitable due to causing gynecomastia side-effects (e.g., in place of taking spironolactone the alternative eplerenone can be used).

Selective estrogen receptor modulator medications, such as tamoxifen and clomiphene, or androgens or aromatase inhibitors such as Letrozole are medical treatment options, although they are not universally approved for the treatment of gynecomastia. Endocrinological attention may help during the first 2-3 years.

Treatment: surgical
After the above non-surgical options, however, the breast tissue tends to remain and harden, leaving surgery the only treatment option.
The surgical methods include:
• Liposuction;
• Gland excision;
• Skin sculpture;
• Reduction mammoplasty; or
• Combination of these surgical techniques.

 

The surgical procedure
Usually performed in a doctor's office or surgical suite as an outpatient procedure, gynecomastia surgery can be done with the use of a local or general anesthetic.

Once the patient is properly anesthetized, the surgeon makes a small incision just below the areola.  Excess breast tissue is surgically excised from the area and fat is removed with the use of liposuction.  The incision is then closed and the patient is detained until the effects of the anesthesia wear off.


Recovery
After surgery you will be fitted with a compression garment or ace bandages to support the breasts while they heal.  The recovery process is usually not a short one.  Patients should take their time when thinking about returning to normal activity, and are usually told to ease back into their daily routine gradually.  In many instances patients will wait between one and three weeks before returning to work.


Complications
Most instances of complications stem from surgeon error and patients trying to do too much after surgery.  The most serious complications include:
• Hematoma (collection of blood);
• Asymmetry;
• Infection;
• Change in position or shape of the nipple; and
• Wound separation.
More common complications include:
• Numbness;
• Swelling;
• Bruising, and
• Scarring.


Who can be a candidate?
Men who have developed larger, female-like breasts and have not been able to alter this problem with diet and lifestyle changes can be candidates for surgery.


Average costs
Including costs of anesthesia and other necessary equipment and medications costs can average $2,000 to $6,000 or more, depending on the clinic and the geographic location.

More Hiroshima info...


  • Hiroshima Other museums
    The Hiroshima Museum of Art (3-2 Motomachi, Naka-ku, Tel. 082-223-2530. Open 9am - 5pm, closed 12/29 - 1/2; admission ¥1200 adults, ¥900 high school students, ¥500 junior high and elementary school students) [5] was established by the Hiroshima Bank in 1978. The permanent collection covers European art from late Romanticism to early Picasso, including a couple of Japanese painters who painted in Western styles. It's a ruthlessly stratified selection: at least one painting by every Famous Artist of the period, but no major works by any of them. It's on the other side of Jonan-dori from Hiroshima Castle. Take tram lines 1, 2 or 6 to Kamiya-cho (a big intersection just before the Peace Park) and walk two minutes north. It's included in the route of the sightseeing buses that leave from JR Hiroshima Station. -


  • Hiroshima By train
    Hiroshima is a major station on the Sanyo Shinkansen line. It is 40 minutes away from Okayama (¥5860 by Nozomi) and 90 minutes from Shin-Osaka (¥9950 by Nozomi). Regular local and rapid trains on the Sanyo Line reach Hiroshima in as little as 6 hours (¥5460).

    From Tokyo it is four hours via Nozomi; five hours via Hikari (change trains once at Shin-Osaka or Okayama). Be very careful about taking a Kodama for the last leg of the journey; Hikari and Kodama services are valid under the Japan Rail Pass, but the all-stations Kodama service will add up to two hours to your trip.

    Cheaper but slower local services radiate out to other cities in the region.
    -

Plastic Surgery News...

  • BioSpace has reported briefly on Phase III data for retigabine, a first-in-class neuronal potassium channel opener which is in development as an adjunct in the treatment of adult epilepsy patients with refractory partial-onset seizures. The double-blind trial – RESTORE 1 (Retigabine Efficacy and Safety Trials for Partial Onset Epilepsy) – randomised 306 adults who were experiencing refractory partial-onset seizures despite receiving stable doses of up to three anti-epileptics to additional treatment with retigabine (400mg TDS; n=151) or placebo (n=150). Study duration was 32 weeks including 8 weeks baseline phase, 6 weeks titration phase, 12 weeks maintenance phase and 6 weeks transition phase. Only brief details of the study are included in the BioSpace abstract which prevents a full evaluation of the findings; however the following results were reported: • The median reduction in 28-day total partial seizure frequency was 44.3% in the retigabine group and 17.5% in the placebo group (p<0.0001) • The median reduction in 28-day total partial seizure frequency during the maintenance phase was 54.5% versus 18.9%, respectively (p<0.0001) • The responder rate (at least a 50% reduction in 28-day total partial seizure frequency) was 45.0% versus 18.0%, respectively (p<0.0001) • The responder rate during the maintenance phase was 55.5% versus 22.6%, respectively (p<0.0001) Results from RESTORE 2, the second pivotal Phase III clinical trial studying lower doses of retigabine, are expected during the second quarter of 2008. The company anticipate filing a Marketing Authorization Application (MAA) to the EMEA before the end of the year.

  • Neuro-Hitech, Inc. (NASDAQ: NHPI), a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegenerative diseases, announced top-line results from the double-blind part of a phase 2 clinical trial of Huperzine A in mild to moderate Alzheimer's disease (AD) patients.

Ask A Local Surgeon
From Hiroshima

»Have a Local Immersivemedical member contact you«

Gynecomastia Surgery Surgeons in Hiroshima

Your Clinic NameYour Clinic Name
Join us and get your clinic listed here.
also join our referral system and get referring customers in your area.

..



»Add Your clinic Here«»Recommend a Clinic«

Plastic Surgery Articles


»Add Your Article«


Buttock Implants in Hiroshima, Eyelid Surgery in Hiroshima, Body Contouring in Hiroshima, Botox® Cosmetic in Hiroshima, Breast Augmentation in Hiroshima, Breast Reduction in Hiroshima, Buttock Augmentation in Hiroshima, Chemical Peel in Hiroshima, Chin Augmentation in Hiroshima, Correction Of Breast Asymmetry in Hiroshima, Ear Surgery in Hiroshima, Facelift in Hiroshima, Fat Grafting in Hiroshima, Gastric Bypass in Hiroshima, Hair Replacement in Hiroshima, Jaw Surgery in Hiroshima, Lip Augmentation in Hiroshima, Liposuction in Hiroshima, Male Breast Reduction in Hiroshima, Neck Lift in Hiroshima, Penis Enlargement in Hiroshima, Spider Vein Treatment in Hiroshima, Breast Reconstruction in Hiroshima, Nose Reshaping in Hiroshima, Dermabrasion in Hiroshima, Vaginal Surgery in Hiroshima, Medical Tourism in Hiroshima, Plastic Surgeon in Hiroshima, Arm Lift in Hiroshima, Tummy Tuck in Hiroshima, Hyperhydrosis in Hiroshima, Nose Surgery in Hiroshima, Hair Transplant in Hiroshima, Cellulite Treatment in Hiroshima, Hair Removal in Hiroshima, Tattoo Removal in Hiroshima, Cheek Augmentation in Hiroshima, Inverted Nipple Repair in Hiroshima, Skin Resurfacing in Hiroshima, Body Procedures in Hiroshima, Permanent Cosmetics in Hiroshima, Face Procedures in Hiroshima, Skin Surgery1 in Hiroshima, Calf Augmentation in Hiroshima, Birthmark Removal in Hiroshima